{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:04:08Z","timestamp":1791295448381,"version":"4.1.0"},"reference-count":145,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Narcolepsy type 1 (NT1) is a chronic neurological disorder characterized mainly by impaired wakefulness maintenance and dysregulated rapid eye movement (REM) sleep, which markedly affects patients\u2019 daytime functioning and quality of life. The core pathological basis of NT1 is the selective loss of orexinergic neurons. The orexinergic system regulates histaminergic neurons in the tuberomammillary nucleus (TMN) through anatomical projections and functional excitation, while the histaminergic system contributes to cortical activation, arousal maintenance, and attention regulation. Therefore, the orexinergic and histaminergic systems can be regarded as interconnected and functionally complementary components of the arousal network. Previous studies have suggested alterations in histaminergic signaling in NT1, although the specific mechanisms underlying its role in NT1 remain incompletely understood. Current evidence suggests that histamine may play a modulatory role in NT1-associated phenotypes. This review summarizes the physiological functions of the histaminergic system in arousal regulation and discusses its interaction with the orexinergic system. It further analyzes the role of HA in NT1, its influence on clinical phenotypes, and related therapeutic strategies, with the aim of providing insights for mechanistic research and precision treatment of NT1.<\/jats:p>","DOI":"10.3389\/fneur.2026.1900892","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:49:44Z","timestamp":1791294584000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of histamine in narcolepsy type 1: a narrative review"],"prefix":"10.3389","volume":"17","author":[{"given":"Wei","family":"Liang","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yan","sequence":"additional","affiliation":[{"name":"Brain Disease Center, The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Rehabilitation Department, Brain Disease Center, The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongnan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Rehabilitation Department, Brain Disease Center, The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[{"name":"Rehabilitation Department, Brain Disease Center, The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Sui","sequence":"additional","affiliation":[{"name":"Rehabilitation Department, Brain Disease Center, The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Brain Disease Center, The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"116390","DOI":"10.1016\/j.psychres.2025.116390","article-title":"Prevalence of narcolepsy in representative samples of the general population of North America, Europe, and South Korea","volume":"347","author":"Ohayon","year":"2025","journal-title":"Psychiatry Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/nejmra1500587","article-title":"Narcolepsy","volume":"373","author":"Scammell","year":"2015","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2147\/NSS.S359980","article-title":"Idling for decades: a European study on risk factors associated with the delay before a narcolepsy diagnosis","volume":"14","author":"Zhang","year":"2022","journal-title":"Nat Sci Sleep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40263-024-01141-9","article-title":"Narcolepsy: beyond the classic pentad","volume":"39","author":"Morse","year":"2025","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.smrv.2017.04.003","article-title":"The clinical spectrum of childhood narcolepsy","volume":"38","author":"Postiglione","year":"2018","journal-title":"Sleep Med Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0035-1550152","article-title":"Narcolepsy during childhood: an update","volume":"46","author":"Rocca","year":"2015","journal-title":"Neuropediatrics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","article-title":"The neurobiological basis of narcolepsy","volume":"20","author":"Mahoney","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0092-8674(00)81973-x","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MCP.0000000000000426","article-title":"Autoimmunity in narcolepsy","volume":"23","author":"Bonvalet","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"902840","DOI":"10.3389\/fimmu.2022.902840","article-title":"Narcolepsy and H1N1 influenza immunology a decade later: what have we learned?","volume":"13","author":"Buonocore","year":"2022","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","article-title":"T cells in patients with narcolepsy target self-antigens of hypocretin neurons","volume":"562","author":"Latorre","year":"2018","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1073\/pnas.96.2.748","article-title":"Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems","volume":"96","author":"Date","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bph.15220","article-title":"Histaminergic neurons in the tuberomammillary nucleus as a control Centre for wakefulness","volume":"178","author":"Yoshikawa","year":"2021","journal-title":"Br J Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"9574","DOI":"10.1523\/JNEUROSCI.0580-17.2017","article-title":"Hypothalamic Tuberomammillary nucleus neurons: electrophysiological diversity and essential role in arousal stability","volume":"37","author":"Fujita","year":"2017","journal-title":"J Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"7695","DOI":"10.1523\/JNEUROSCI.22-17-07695.2002","article-title":"Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control","volume":"22","author":"Parmentier","year":"2002","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/sleep\/32.2.175","article-title":"Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls","volume":"32","author":"Nishino","year":"2009","journal-title":"Sleep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/sleep\/32.2.181","article-title":"CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome","volume":"32","author":"Kanbayashi","year":"2009","journal-title":"Sleep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/j.1365-2869.2010.00819.x","article-title":"Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin","volume":"19","author":"Bassetti","year":"2010","journal-title":"J Sleep Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ab.2010.09.045","article-title":"Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization","volume":"409","author":"Croyal","year":"2011","journal-title":"Anal Biochem"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"zsw010","DOI":"10.1093\/sleep\/zsw010","article-title":"Temporal changes in the cerebrospinal fluid level of Hypocretin-1 and histamine in narcolepsy","volume":"40","author":"Lopez","year":"2017","journal-title":"Sleep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e13027","DOI":"10.1111\/bpa.13027","article-title":"Histamine in murine narcolepsy: what do genetic and immune models tell us?","volume":"32","author":"Melzi","year":"2022","journal-title":"Brain Pathol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e0140520","DOI":"10.1371\/journal.pone.0140520","article-title":"Histamine transmission modulates the phenotype of murine narcolepsy caused by orexin neuron deficiency","volume":"10","author":"Bastianini","year":"2015","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/cne.903300309","article-title":"Histaminergic system in the cat hypothalamus with reference to type B monoamine oxidase","volume":"330","author":"Lin","year":"1993","journal-title":"J Comp Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol Rev"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Med Rev"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1523\/JNEUROSCI.1887-05.2005","article-title":"Discharge of identified orexin\/hypocretin neurons across the sleep-waking cycle","volume":"25","author":"Lee","year":"2005","journal-title":"J Neurosci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000108341","article-title":"Histamine and the regulation of body weight","volume":"86","author":"J\u00f8rgensen","year":"2007","journal-title":"Neuroendocrinology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9524075","article-title":"Role of histamine in modulating the immune response and inflammation","volume":"2018","author":"Branco","year":"2018","journal-title":"Mediat Inflamm"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1073\/pnas.81.8.2572","article-title":"Histamine-containing neurons in the rat hypothalamus","volume":"81","author":"Panula","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrn1034","article-title":"The role of histamine and the tuberomamillary nucleus in the nervous system","volume":"4","author":"Haas","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.smrv.2012.08.001","article-title":"Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications","volume":"17","author":"Krystal","year":"2013","journal-title":"Sleep Med Rev"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1523\/JNEUROSCI.2341-06.2006","article-title":"Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse","volume":"26","author":"Takahashi","year":"2006","journal-title":"J Neurosci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0166-4328(01)00222-4","article-title":"Modifying effects of histamine on circadian rhythms and neuronal excitability","volume":"124","author":"Tuomisto","year":"2001","journal-title":"Behav Brain Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0014-4886(68)90048-4","article-title":"Effects of promethazine on sleep stages in the cat","volume":"21","author":"Jewett","year":"1968","journal-title":"Exp Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/0028-3908(81)90078-2","article-title":"A comparison between astemizole and other antihistamines on sleep-wakefulness cycles in dogs","volume":"20","author":"Wauquier","year":"1981","journal-title":"Neuropharmacology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF00429264","article-title":"Effects of promethazine on nocturnal sleep in normal man","volume":"43","author":"Risberg","year":"1975","journal-title":"Psychopharmacologia"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-3565(25)33149-6","article-title":"Histamine-induced arousal in the conscious and pentobarbital-pretreated rat","volume":"222","author":"Kalivas","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1073\/pnas.0600451103","article-title":"Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice","volume":"103","author":"Huang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.resp.2006.01.017","article-title":"Impaired ventilation and metabolism response to hypoxia in histamine H1 receptor-knockout mice","volume":"154","author":"Ishiguro","year":"2006","journal-title":"Respir Physiol Neurobiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuropharm.2015.12.014","article-title":"Role of histamine H1-receptor on behavioral states and wake maintenance during deficiency of a brain activating system: a study using a knockout mouse model","volume":"106","author":"Parmentier","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2500\/aap.2009.30.3264","article-title":"Histamine, antihistamines, and the central nervous system","volume":"30","author":"Lieberman","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.brainresrev.2010.04.008","article-title":"Cognitive domains affected by histamine H(1)-antagonism in humans: a literature review","volume":"64","author":"Van Ruitenbeek","year":"2010","journal-title":"Brain Res Rev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1517\/14740338.2011.562889","article-title":"Positron emission tomography evaluation of sedative properties of antihistamines","volume":"10","author":"Yanai","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International union of basic and clinical pharmacology. XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol Rev"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0306-4522(02)00135-5","article-title":"A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain","volume":"114","author":"Pillot","year":"2002","journal-title":"Neuroscience"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0306-4522(87)90279-X","article-title":"Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors","volume":"23","author":"Arrang","year":"1987","journal-title":"Neuroscience"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/mol.116.104752","article-title":"The histamine H3 receptor: structure, pharmacology, and function","volume":"90","author":"Nieto-Alamilla","year":"2016","journal-title":"Mol Pharmacol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00018-011-0631-8","article-title":"The waking brain: an update","volume":"68","author":"Lin","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0006-8993(90)91508-E","article-title":"Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat","volume":"523","author":"Lin","year":"1990","journal-title":"Brain Res"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0014-2999(91)90911-9","article-title":"Effects of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness","volume":"205","author":"Monti","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2174\/156802608784936728","article-title":"Histamine H3 antagonists as wake-promoting and pro-cognitive agents","volume":"8","author":"Stocking","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/jpet.109.158444","article-title":"Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats","volume":"332","author":"Giannoni","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1124\/jpet.107.120311","article-title":"GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models","volume":"321","author":"Medhurst","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/medicines7090055","article-title":"Pitolisant and other histamine-3 receptor antagonists-an update on therapeutic potentials and clinical prospects","volume":"7","author":"Harwell","year":"2020","journal-title":"Medicines Basel"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2147\/NSS.S264140","article-title":"Pitolisant to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy: rationale and clinical utility","volume":"12","author":"Guevarra","year":"2020","journal-title":"Nat Sci Sleep"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1006\/bbrc.2001.6318","article-title":"Orexins activate histaminergic neurons via the orexin 2 receptor","volume":"290","author":"Yamanaka","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","article-title":"Orexin\/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus","volume":"21","author":"Eriksson","year":"2001","journal-title":"J Neurosci"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"12437","DOI":"10.1523\/JNEUROSCI.0706-12.2012","article-title":"Optogenetic probing of fast glutamatergic transmission from hypocretin\/orexin to histamine neurons in situ","volume":"32","author":"Sch\u00f6ne","year":"2012","journal-title":"J Neurosci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"9965","DOI":"10.1073\/pnas.181330998","article-title":"Arousal effect of orexin a depends on activation of the histaminergic system","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/biom11091345","article-title":"The histaminergic system in neuropsychiatric disorders","volume":"11","author":"Cheng","year":"2021","journal-title":"Biomolecules"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.cub.2025.03.040","article-title":"An orexin agonist promotes wakefulness and inhibits cataplexy through distinct brain regions","volume":"35","author":"Ishikawa","year":"2025","journal-title":"Curr Biol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1096\/fj.11-188268","article-title":"The histaminergic system regulates wakefulness and orexin\/hypocretin neuron development via histamine receptor H1 in zebrafish","volume":"25","author":"Sundvik","year":"2011","journal-title":"FASEB J"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1111\/j.1460-9568.2009.06765.x","article-title":"Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat","volume":"29","author":"Giannoni","year":"2009","journal-title":"Eur J Neurosci"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00424-011-0996-4","article-title":"Waking with the hypothalamus","volume":"463","author":"Haas","year":"2012","journal-title":"Pflugers Arch"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.5665\/sleep.2114","article-title":"Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions","volume":"35","author":"Dauvilliers","year":"2012","journal-title":"Sleep"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/cns.13057","article-title":"Impaired histaminergic neurotransmission in children with narcolepsy type 1","volume":"25","author":"Franco","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/ana.23968","article-title":"Greatly increased numbers of histamine cells in human narcolepsy with cataplexy","volume":"74","author":"John","year":"2013","journal-title":"Ann Neurol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ana.24019","article-title":"Increase of histaminergic tuberomammillary neurons in narcolepsy","volume":"74","author":"Valko","year":"2013","journal-title":"Ann Neurol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"660518","DOI":"10.3389\/fnins.2021.660518","article-title":"Orexin\/Hypocretin and histamine cross-talk on hypothalamic neuron counts in mice","volume":"15","author":"Berteotti","year":"2021","journal-title":"Front Neurosci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"100095","DOI":"10.1016\/j.sleepx.2023.100095","article-title":"Prevalence and incidence of narcolepsy symptoms in the US general population","volume":"6","author":"Ohayon","year":"2023","journal-title":"Sleep Med X"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.5664\/jcsm.9328","article-title":"Treatment of central disorders of hypersomnolence: an American Academy of sleep medicine clinical practice guideline","volume":"17","author":"Maski","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2869.2011.00957.x","article-title":"Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey","volume":"21","author":"Zeitzer","year":"2012","journal-title":"J Sleep Res"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.sleep.2025.02.019","article-title":"Quality of life and its associates in narcolepsy 1 and 2 types and idiopathic hypersomnia","volume":"129","author":"Galu\u0161kov\u00e1","year":"2025","journal-title":"Sleep Med"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/bmj.329.7468.724","article-title":"Narcolepsy and excessive daytime sleepiness","volume":"329","author":"Zeman","year":"2004","journal-title":"BMJ"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"zsy183","DOI":"10.1093\/sleep\/zsy183","article-title":"Histamine: neural circuits and new medications","volume":"42","author":"Scammell","year":"2019","journal-title":"Sleep"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5664\/jcsm.9638","article-title":"Disrupted nighttime sleep and sleep instability in narcolepsy","volume":"18","author":"Maski","year":"2022","journal-title":"J Clin Sleep Med"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"101488","DOI":"10.1016\/j.smrv.2021.101488","article-title":"Polysomnographic nighttime features of narcolepsy: a systematic review and meta-analysis","volume":"58","author":"Zhang","year":"2021","journal-title":"Sleep Med Rev"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/sleep\/30.8.980","article-title":"Insufficient non-REM sleep intensity in narcolepsy-cataplexy","volume":"30","author":"Khatami","year":"2007","journal-title":"Sleep"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.5665\/sleep.2880","article-title":"Sleep transitions in hypocretin-deficient narcolepsy","volume":"36","author":"Sorensen","year":"2013","journal-title":"Sleep"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.5665\/sleep.5750","article-title":"Hypocretin-1 levels associate with fragmented sleep in patients with narcolepsy type 1","volume":"39","author":"Alakuijala","year":"2016","journal-title":"Sleep"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"zsy026","DOI":"10.1093\/sleep\/zsy026","article-title":"The distinguishing motor features of cataplexy: a study from video-recorded attacks","volume":"41","author":"Pizza","year":"2018","journal-title":"Sleep"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrneurol.2014.97","article-title":"Cataplexy\u2014clinical aspects, pathophysiology and management strategy","volume":"10","author":"Dauvilliers","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0896-6273(04)00247-8","article-title":"Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior","volume":"42","author":"John","year":"2004","journal-title":"Neuron"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"101976","DOI":"10.1016\/j.smrv.2024.101976","article-title":"REM sleep in narcolepsy","volume":"77","author":"Thorpy","year":"2024","journal-title":"Sleep Med Rev"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrneurol.2015.99","article-title":"Interactions of the histamine and hypocretin systems in CNS disorders","volume":"11","author":"Shan","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin\u2212\/\u2212 mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s13311-020-00966-8","article-title":"Nightmare disorder and isolated sleep paralysis","volume":"18","author":"Stefani","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1748-1716.2009.02012.x","article-title":"Hypocretin\/orexin and narcolepsy: new basic and clinical insights","volume":"198","author":"Nishino","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.genhosppsych.2008.12.002","article-title":"Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia","volume":"31","author":"Fortuyn","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/schbul\/sbw076","article-title":"What is the link between hallucinations, dreams, and hypnagogic-hypnopompic experiences?","volume":"42","author":"Waters","year":"2016","journal-title":"Schizophr Bull"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0149-7634(99)00053-6","article-title":"Central histaminergic system and cognition","volume":"24","author":"Passani","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fnsys.2012.00033","article-title":"Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations?","volume":"6","author":"Blandina","year":"2012","journal-title":"Front Syst Neurosci"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnsys.2012.00051","article-title":"Histamine and motivation","volume":"6","author":"Torrealba","year":"2012","journal-title":"Front Syst Neurosci"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"zpae043","DOI":"10.1093\/sleepadvances\/zpae043","article-title":"The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysis","volume":"5","author":"Harel","year":"2024","journal-title":"Sleep Adv"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S1474-4422(16)30333-7","article-title":"Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Szakacs","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"zsz174","DOI":"10.1093\/sleep\/zsz174","article-title":"Long-term use of pitolisant to treat patients with narcolepsy: Harmony III study","volume":"42","author":"Dauvilliers","year":"2019","journal-title":"Sleep"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/brain\/awr244","article-title":"Complex movement disorders at disease onset in childhood narcolepsy with cataplexy","volume":"134","author":"Plazzi","year":"2011","journal-title":"Brain"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/brain\/awx096","article-title":"The spectrum of REM sleep-related episodes in children with type 1 narcolepsy","volume":"140","author":"Antelmi","year":"2017","journal-title":"Brain"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1212\/WNL.0000000000200666","article-title":"Child neurology: a case series of heterogeneous neuropsychiatric symptoms and outcome in very early-onset narcolepsy type 1","volume":"98","author":"Veneruso","year":"2022","journal-title":"Neurology"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/cns.13811","article-title":"Characterization of rapid weight gain phenotype in children with narcolepsy","volume":"28","author":"Zhang","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"zsad076","DOI":"10.1093\/sleep\/zsad076","article-title":"Metabolic disturbances in children with narcolepsy: a retrospective study","volume":"46","author":"Zhang","year":"2023","journal-title":"Sleep"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1037398","DOI":"10.3389\/fendo.2023.1037398","article-title":"Auxological and endocrine findings in narcolepsy type 1: seventeen-year follow-up from a pediatric endocrinology center","volume":"14","author":"Casale","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1202089","DOI":"10.3389\/fendo.2023.1202089","article-title":"Histaminergic regulation of food intake","volume":"14","author":"Khouma","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.2174\/092986710794182944","article-title":"Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity","volume":"17","author":"Masaki","year":"2010","journal-title":"Curr Med Chem"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40263-020-00703-x","article-title":"Pitolisant: a review in narcolepsy with or without cataplexy","volume":"34","author":"Lamb","year":"2020","journal-title":"CNS Drugs"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40263-019-00689-1","article-title":"Recently approved and upcoming treatments for narcolepsy","volume":"34","author":"Thorpy","year":"2020","journal-title":"CNS Drugs"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00213-021-05779-x","article-title":"Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation","volume":"238","author":"Nirogi","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"105425","DOI":"10.1016\/j.ejps.2020.105425","article-title":"Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H(3)R) inverse agonist in clinical development for the treatment of narcolepsy","volume":"152","author":"Nirogi","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.sleep.2024.10.037","article-title":"Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy","volume":"124","author":"Nirogi","year":"2024","journal-title":"Sleep Med"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"zsae244","DOI":"10.1093\/sleep\/zsae244","article-title":"Pharmacological inhibition of histamine N-methyltransferase extends wakefulness and suppresses cataplexy in a mouse model of narcolepsy","volume":"48","author":"Naganuma","year":"2025","journal-title":"Sleep"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"15899","DOI":"10.1038\/s41598-017-16019-8","article-title":"Histamine N-methyltransferase regulates aggression and the sleep-wake cycle","volume":"7","author":"Naganuma","year":"2017","journal-title":"Sci Rep"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00011-004-1268-y","article-title":"Cardiac and regional haemodynamic effects of histamine N-methyltransferase inhibitor metoprine in haemorrhage-shocked rats","volume":"53","author":"Jochem","year":"2004","journal-title":"Inflamm Res"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/ijms20030737","article-title":"Histamine N-Methyltransferase in the brain","volume":"20","author":"Yoshikawa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"20838","DOI":"10.1038\/s41598-024-70594-1","article-title":"TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models","volume":"14","author":"Mitsukawa","year":"2024","journal-title":"Sci Rep"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/nejmoa2405847","article-title":"Oveporexton, an oral orexin receptor 2-selective agonist, in narcolepsy type 1","volume":"392","author":"Dauvilliers","year":"2025","journal-title":"N Engl J Med"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/toxsci\/kfaf003","article-title":"TAK-994 mechanistic investigation into drug-induced liver injury","volume":"204","author":"Shinozawa","year":"2025","journal-title":"Toxicol Sci"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1056\/nejmoa2301940","article-title":"Oral orexin receptor 2 agonist in narcolepsy type 1","volume":"389","author":"Dauvilliers","year":"2023","journal-title":"N Engl J Med"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"e13839","DOI":"10.1111\/jsr.13839.","article-title":"Evaluation of the efficacy of the hypocretin\/orexin receptor agonists TAK-925 and ARN-776 in narcoleptic orexin\/tTA; TetO-DTA mice","volume":"32","author":"Sun","year":"2023","journal-title":"J Sleep Res"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1124\/jpet.122.001449","article-title":"TAK-994, a novel orally available brain-penetrant orexin 2 receptor-selective agonist, suppresses fragmentation of wakefulness and cataplexy-like episodes in mouse models of narcolepsy","volume":"385","author":"Ishikawa","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1415918","DOI":"10.3389\/fphar.2024.1415918","article-title":"Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"e13387","DOI":"10.1111\/jsr.13387","article-title":"European guideline and expert statements on the management of narcolepsy in adults and children","volume":"30","author":"Bassetti","year":"2021","journal-title":"J Sleep Res"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","article-title":"Clinical and practical considerations in the pharmacologic management of narcolepsy","volume":"16","author":"Thorpy","year":"2015","journal-title":"Sleep Med"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40263-024-01150-8","article-title":"Therapeutic use of \u03b3-Hydroxybutyrate: history and clinical utility of Oxybates and considerations of once- and twice-nightly dosing in narcolepsy","volume":"39","author":"Roth","year":"2025","journal-title":"CNS Drugs"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"596","DOI":"10.5664\/jcsm.27994","article-title":"The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy","volume":"6","author":"Black","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/jsr.12468","article-title":"Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy","volume":"26","author":"Roth","year":"2017","journal-title":"J Sleep Res"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40263-022-00904-6","article-title":"Effect of FT218, a once-nightly sodium Oxybate formulation, on disrupted nighttime sleep in patients with narcolepsy: results from the randomized phase III REST-ON trial","volume":"36","author":"Roth","year":"2022","journal-title":"CNS Drugs"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.sleepx.2024.100122","article-title":"RESTORE: once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates","volume":"8","author":"Roy","year":"2024","journal-title":"Sleep Med X."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40263-024-01144-6","article-title":"Sodium Oxybate: practical considerations and patient perspectives","volume":"39","author":"Lavender","year":"2025","journal-title":"CNS Drugs"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/17460441.2022.1999226","article-title":"Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia","volume":"17","author":"Junnarkar","year":"2022","journal-title":"Expert Opin Drug Discov"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5664\/jcsm.27549","article-title":"Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion","volume":"5","author":"Wang","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"12305","DOI":"10.1523\/JNEUROSCI.2630-12.2012","article-title":"Narcolepsy: neural mechanisms of sleepiness and cataplexy","volume":"32","author":"Burgess","year":"2012","journal-title":"J Neurosci"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/14656566.2017.1323877","article-title":"Pharmacological management of narcolepsy with and without cataplexy","volume":"18","author":"Kallweit","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"CD003724","DOI":"10.1002\/14651858.CD003724.pub3","article-title":"Antidepressant drugs for narcolepsy","volume":"2008","author":"Vignatelli","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.sleep.2008.04.004","article-title":"Exacerbation of cataplexy following gradual withdrawal of antidepressants: manifestation of probable protracted rebound cataplexy","volume":"10","author":"Ristanovic","year":"2009","journal-title":"Sleep Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1900892\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:49:46Z","timestamp":1791294586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1900892\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":145,"alternative-id":["10.3389\/fneur.2026.1900892"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1900892","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1900892"}}